(S (NP-SBJ (JJ Retinoic) (NN acid)) (VP (VBZ downmodulates) (NP (NP-COOD (NP (JJ erythroid) (NN differentiation)) (CC and) (NP (NN GATA1) (NN expression))) (PP (IN in) (NP (VBN purified) (JJ adult-progenitor) (NN culture))))) (. .))
(S (NP-SBJ-1 (JJ All-trans) (NP (NP (JJ retinoic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-)))) (VP-COOD (VP (VBZ is) (NP-PRD (NP (NP (DT an) (JJ important) (NN morphogen)) (PP (IN in) (NP (NN vertebrate) (NN development)))) (, ,) (NP (NP (DT a) (JJ normal) (NN constituent)) (PP (IN in) (NP (JJ human) (JJ adult) (NN blood)))))) (CC and) (VP (VBZ is) (VP (ADVP (RB also)) (VP (VBN involved) (NP (-NONE- *-1)) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NP (NN cell) (NP-COOD (NP (NN growth)) (CC and) (NP (NN differentiation)))) (PP (IN in) (NP (JJ acute) (JJ promyelocytic) (NN leukemia))))))))))) (. .))
(S (NP-SBJ-2 (PRP We)) (VP (VBP have) (VP (VBN examined) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN RA))) (PP (IN on) (NP (JJ normal) (NN hematopoiesis)))) (PP (IN by) (S (NP-SBJ (-NONE- *-2)) (VP (VBG using) (NP (NP (JJ early) (NP (NP (JJ hematopoietic) (NN progenitor) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN HPC)) (-RRB- -RRB-)))) (VP (ADVP (RB stringently)) (VBN purified) (NP (-NONE- *)) (PP (IN from) (NP (JJ adult) (JJ peripheral) (NN blood)))))))))) (. .))
(S (PP (IN In) (NP (NP (JJ clonogenetic) (ADJP-COOD (ADJP (ADJP (JJ fetal) (NN calf) (JJ serum-supplemented)) (PRN (-LRB- -LRB-) (ADJP (JJ FCS+)) (-RRB- -RRB-))) (CC or) (ADJP (ADJP (NP (-NONE- *?*)) (JJ -nonsupplemented)) (PRN (-LRB- -LRB-) (ADJP (JJ FCS-)) (-RRB- -RRB-)))) (NN culture)) (VP (VBN treated) (NP (-NONE- *)) (PP (IN with) (NP (NP (JJ saturating) (NNS levels)) (PP (IN of) (NP-COOD (NP (NP (NP (NN interleukin-3)) (PRN (-LRB- -LRB-) (NP (NN IL-3)) (-RRB- -RRB-))) (NP (NP (JJ granulocyte-macrophage) (JJ colony-stimulating) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN GM-CSF)) (-RRB- -RRB-)))) (CC and) (NP (NP (NP (NN erythropoietin)) (PRN (-LRB- -LRB-) (NP (NN Ep)) (-RRB- -RRB-))) (-LRB- -LRB-) (PP (VBN combined) (PP (IN with) (NP (NP (NN c-kit) (NN ligand)) (PP (IN in) (NP (JJ FCS-LRB---RRB--culture) (NNS conditions)))))) (-RRB- -RRB-))))))))) (, ,) (NP-SBJ (NN RA)) (VP (VBZ induces) (NP (NP (DT a) (JJ dramatic) (JJ dose-dependent) (NN shift)) (PP (IN from) (NP (JJ erythroid) (NP (-NONE- *RNR*-3)))) (PP (TO to) (NP (JJ granulomonocytic) (NP (-NONE- *RNR*-3)))) (NP-3 (NN colony) (NN formation))) (, ,) (S (NP-SBJ-4 (DT the) (JJ latter) (NNS colonies)) (VP (VBG being) (VP (ADVP (RB essentially)) (VBN represented) (NP (-NONE- *-4)) (PP (IN by) (NP-LGS (JJ granulocytic) (NNS clones))))))) (. .))
(S (NP-SBJ-5 (DT This) (NN shift)) (VP (VBZ is) (ADVP (RB apparently)) (RB not) (VP (VBN caused) (NP (-NONE- *-5)) (PP (IN by) (NP-LGS (DT a) (NN recruitment) (NN phenomenon))) (, ,) (SBAR (IN because) (S (PP (IN in) (NP (JJ FCS+) (NN culture))) (, ,) (NP-SBJ-6 (NP (DT the) (JJ total) (NN number)) (PP (IN of) (NP (NNS colonies)))) (VP (VBZ is) (RB not) (VP (ADVP (RB significantly)) (VBN modified) (NP (-NONE- *-6)) (PP (IN by) (NP-LGS (NN RA) (NN addition))))))))) (. .))
(S (S (PP (IN In) (NP (NP (JJ FCS-) (NN liquid-suspension) (NN culture)) (VP (VBN supplemented) (NP (-NONE- *)) (PP (IN with) (NP-COOD (NP (JJ saturating) (NN Ep) (NN level)) (CC and) (NP (JJ low-dose) (NN (GM-CSF IL-3)))))))) (, ,) (NP-SBJ (JJ adult) (NN HPC)) (VP (VBP undergo) (NP (JJ unilineage) (JJ erythropoietic) (NN differentiation))) (: :)) (S (ADVP (RB Here)) (ADVP-TMP (RB again)) (, ,) (NP-SBJ (NP (NN treatment)) (PP (IN with) (NP (JJ high-dose) (NN RA)))) (VP (VBZ induces) (NP (NP (DT a) (NN shift)) (PP (IN from) (NP (DT the) (ADJP-COOD (ADJP (JJ erythroid)) (TO to) (ADJP (JJ granulocytic))) (NN differentiation) (NN pathway))))) (. .)))
(S (NP-SBJ-7 (NP (NNS Studies)) (PP (IN on) (NP (NP (NN RA) (UCP-COOD (ADJP (JJ time-response)) (CC or) (NP (NN pulse))) (NN treatment)) (PP (IN in) (NP (ADJP-COOD (ADJP (JJ semisolid)) (CC or) (ADJP (JJ liquid))) (NN culture)))))) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ (JJ early) (NN RA) (NN addition)) (VP (VBZ is) (ADJP-PRD (RBS most) (JJ effective))))) (, ,) (S (NP-SBJ (-NONE- *-7)) (ADVP (RB thus)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ (ADJP-COOD (ADJP (JJ early)) (CC but) (ADJP (RB not) (JJ late))) (NN HPC)) (VP (VBP are) (ADJP-PRD (JJ sensitive) (PP (TO to) (NP (PRP$ its) (NN action)))))))))) (. .))
(S (S (NP-SBJ (PRP We)) (ADVP-TMP (RB then)) (VP (VBD analyzed) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (DT the) (NN master) (NN GATA1) (NN gene)) (, ,) (SBAR (WHNP-8 (WDT which)) (S (NP-SBJ (-NONE- *T*-8)) (VP (VBZ encodes) (NP (NP (DT a) (NN finger) (NN transcription) (NN factor)) (VP (VBN required) (NP (-NONE- *)) (PP (IN for) (NP (JJ normal) (JJ erythroid) (NN development)))))))))))) (: ;)) (S (NP-SBJ (NP (NN addition)) (PP (IN of) (NP (NN RA))) (PP (TO to) (NP (NP (NN HPC)) (VP (VBN stimulated) (NP (-NONE- *)) (PP (IN into) (NP (JJ unilineage) (JJ erythropoietic) (NN differentiation))) (PP (IN in) (NP (JJ liquid) (NN culture))))))) (VP (VBD caused) (NP (NP (DT a) (ADJP (RB virtually) (JJ complete)) (NN inhibition)) (PP (IN of) (NP (NN GATA1) (NN mRNA) (NN induction))))) (. .)))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ (NN RA)) (ADVP (RB directly)) (VP-COOD (VP (VBZ inhibits) (NP (DT the) (JJ erythroid) (NN differentiation) (NN program)) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (JJ early) (JJ adult) (NN HPC)))))) (, ,) (CC and) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (DT a) (NN shift)) (PP (IN from) (NP (DT the) (ADJP-COOD (ADJP (JJ erythroid)) (TO to) (ADJP (JJ granulocytic))) (NN differentiation) (NN pathway))))))))))) (. .))
(S (NP-SBJ-9 (DT This) (NN phenomenon)) (VP (VBZ is) (VP (VBN correlated) (NP (-NONE- *-9)) (PP (IN with) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN GATA1) (NN induction))) (PP (IN in) (NP (NP (DT the) (JJ early) (NNS stages)) (PP (IN of) (NP (JJ erythropoietic) (NN differentiation))))))))) (. .))
